Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) has established a new anti-infective research unit at the Murdoch Children's Research Institute in Melbourne, one of the top three children’s research institutes in the world.
Securing this research space supports the company’s expanding pre-clinical programs with world-leading infectious disease researchers who are dedicating their efforts to a suite of pre-clinical studies investigating the antimicrobial activity of RECCE® compounds.
Brickability Group PLC (AIM:BRCK) reported to the market that chief operating officer Paul Hamilton bought 200,000 shares in the company, priced at 66.7p, on 14 December. It increases his holding to some 20.2mln shares or 6.7% of the brickmaker.
88 Energy Ltd (AIM:88E, ASX:88E, OTC:EEENF)said it has posted a new corporate presentation onto its website.
Avation PLC (LSE:AVAP) issued a statement detailing the extension to a tender offer to buy back loan notes.
Rainbow Rare Earths Ltd (LSE:RBW, OTC:RBWRF) chief financial officer Pete Gardner bought 400,000 shares in the company, at an average price of 10p, according to a regulatory statement.